News About: Pharm. Industry
AstraZeneca Korea Completes Reorganization of Business Units
With the total revenue surpassing over 100 billion won from last year, AstraZeneca Korea recently completed a reorganization of company functions under its plan to drive growth on a long-term basis.
According to th...
Cialis Approved for 36-Hour Effectiveness Duration by KFDA
Lilly Korea recently announced that its male erectile dysfunction treatment, Cialis, has been approved by the Korea Food and Drug Administration (KFDA) for an extended duration of effectiveness lasting up to 36 hours....
KPMA Launches Upgraded Official Website
The Korea Pharmaceutical Manufacturers Association (KPMA) recently completed the upgrade effort on its official website, www.kpma.or.kr, to further strengthen the user-oriented services with added convenience.
Amon...
Multinational Firms Outlay New Product Introductions
The multinational pharmaceutical companies operating in Korea are entering the new year with their business plans to introduce new product lineups to the market, in addition to strengthen the existing products to furt...
Taejoon Introduced New Ethical Products for Ophthalmologic and Gastric Disorders
Taejoon Pharmaceutical has recently made an introduction of new ethical products in two therapeutic areas of retinopathy and gastric ulcer, to be launched in the domestic market under an aggressive marketing promotion...
CJ Launches Domestic Sale of SSI's Tuberculosis Vaccine
CJ Pharmaceutical Division said, effective January 1st, it has launched the domestic sale of BCG Vaccine SSI, under an exclusive distribution agreement made last year with Denmark-based Statens Serum Institute (SSI).A...
Manufacturers Ask for Considerations Towards Small Packaging Requirement
In response to a number of debates and issues surrounding the government's plan to impose the drug small packaging requirement, the pharmaceutical manufacturers are stating that the government should take consideratio...
Yuyu's Maxmavil Receives U.S. Patent
Yuyu announced on January 10th that it has received the U.S. patent for Maxmavil, a novel combination anti-osteoporosis drug formulated with alendronate and calcitrol.
Maxmavil is the first novel combination drug b...
Hexal Korea Launches Marketing Activities for Ethical Generics
Hexal Korea, a local subsidiary of Germany's Hexal AG, has recently launched its marketing activities by introducing four pharmaceutical generic products in the domestic market SimvaHexal, LisiHexal, EnaHexal, and Fl...
Green Cross Appoints New Chief Technology Officer
Green Cross announced the appointment of Dr. Chang Jong-whan as Chief Technology Officer (CTO) and Vice President of the company on January 10th.
Prior to the appointment, Dr. Chang served as the director of resear...
